In-vitro characterization of a novel recombinant oncolytic virus vector for improved therapy of hepatocellular carcinoma
- Weitere Titel
-
In-vitro Charakterisierung eines neuartigen rekombinanten onkolytischen Virus zur verbesserten Therapie des hepatozellulären Karzinoms
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Technische Universität München, Dissertation, 2022
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der TU München
- (wann)
-
2022
- Urheber
-
Conway, Sarah Maria
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:bvb:91-diss-20220906-1633949-1-2
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:44 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Conway, Sarah Maria
- Ebert, Oliver
- Nawroth, Roman
- Universitätsbibliothek der TU München
Entstanden
- 2022
Ähnliche Objekte (12)
Optimization of oncolytic viral therapy for hepatocellular carcinoma
Development of oncolytic viruses as improved therapeutics for hepatocellular carcinoma
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Development of recombinant oncolytic Coxsackievirus B3 for treatment of colorectal carcinoma
Comparative studies of recombinant oncolytic viruses for the treatment of CD133-positive tumors
Comparative studies of recombinant oncolytic viruses for the treatment of CD133-positive tumors
Overproduction of recombinant proteins in bacterial host-vector-systems
Efficient Colonization and Therapy of Human Hepatocellular Carcinoma (HCC) Using the Oncolytic Vaccinia Virus Strain GLV-1h68
Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic virotherapy of glioblastoma
Subclinical hepatocellular carcinoma
Optimization of oncolytic viral therapy for hepatocellular carcinoma
Development of oncolytic viruses as improved therapeutics for hepatocellular carcinoma
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Development of recombinant oncolytic Coxsackievirus B3 for treatment of colorectal carcinoma
Comparative studies of recombinant oncolytic viruses for the treatment of CD133-positive tumors
Comparative studies of recombinant oncolytic viruses for the treatment of CD133-positive tumors
Overproduction of recombinant proteins in bacterial host-vector-systems
Efficient Colonization and Therapy of Human Hepatocellular Carcinoma (HCC) Using the Oncolytic Vaccinia Virus Strain GLV-1h68
Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic virotherapy of glioblastoma
Subclinical hepatocellular carcinoma
Optimization of oncolytic viral therapy for hepatocellular carcinoma
Development of oncolytic viruses as improved therapeutics for hepatocellular carcinoma
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Development of recombinant oncolytic Coxsackievirus B3 for treatment of colorectal carcinoma
Comparative studies of recombinant oncolytic viruses for the treatment of CD133-positive tumors
Comparative studies of recombinant oncolytic viruses for the treatment of CD133-positive tumors
Overproduction of recombinant proteins in bacterial host-vector-systems
Efficient Colonization and Therapy of Human Hepatocellular Carcinoma (HCC) Using the Oncolytic Vaccinia Virus Strain GLV-1h68
Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic virotherapy of glioblastoma